targeting leukemic stem cells in aml
Published 1 year ago • 270 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
0:53
the importance of using novel strategies to target leukemic stem cells more effectively
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:12
an epitope editing approach to enable the use of targeted immunotherapy in aml
-
2:27
session highlights: clonal evolution and leukemic stem cells in aml
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
3:15
using targeted therapies to optimize transplant outcomes in aml
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
5:31
stem cell redux 2022
-
3:35
challenges with implementing mesenchymal stem cells into practice
-
4:01
targeting cancer stem cells
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
0:57
characteristics and clinical implications of leukemic stem cells
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
1:22
pre-leukemic stem cells: a telltale sign of aml
-
1:17
using an ai model to quantify under-utilization of allosct for aml in the uk
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:47
individualized machine learning predictions of allosct outcomes in aml: the harmony platform
-
1:03
personalizing aml treatment by targeting mrd mutations
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents